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The prognosis of children with congenital heart defects(CHDs) continues to improve with advancing surgical techniques;
however, lack of information about modifiable risk factors for malformations in cardiovascular development impeded
the prevention of CHDs. We investigated an association between maternal lifestyle factors and the risk of CHDs, because
epidemiological studies have reported conflicting results regarding maternal lifestyle factors and the risk of CHDs
recently. A review published on 2007 provided a summary of maternal exposures associated with an increased risk of
CHDs. As part of noninherited risk factors, we conducted a brief overview of studies on the evidence linking common
maternal lifestyle factors, specifically smoking, alcohol, illicit drugs, caffeine, body mass index and psychological factors
to the development of CHDs in offspring. Women who smoke and have an excessive body mass index(BMI) during
pregnancy are suspected to be associated with CHDs in offspring. Our findings could cause public health policy
makers to pay more attention to women at risk and could be used in the development of population-based prevention
strategies to reduce the incidence and burden of CHDs. However, more prospective studies are needed to investigate
the association between maternal lifestyle factors and CHDs.
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Congenital heart defects (CHD) are the most common
human birth defects and the leading cause of perinatal
mortality, with an incidence of approximately 4 to 50 per
1000 live birth or even higher [1,2]. With the advancing
surgical techniques, prognosis of children with complicated
and uncomplicated CHDs continues to improve, but the
reported incidence remains unchanged [3]. Clinicians and
basic scientists have long understood the sources of these
cardiovascular developmental errors, and there is wide
acceptance of the opinion that that the etiology of CHD
is complex and possibly lies within the interaction of
environmental exposures and inherited factors [4]. How-
ever, lack of enough information about modifiable risk
factors for malformations in fetal heart development
has impeded the prevention of CHDs.* Correspondence: mohsuming15@sina.com
†Equal contributors
1Department of Cardiothoracic Surgery, The Affiliated Children’s Hospital of
Nanjing Medical University, Nanjing, Jiangsu, P.R. China
Full list of author information is available at the end of the article
© 2014 Feng et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.Although CHDs can occur in the setting of multiple
birth defects as part of a syndrome, most are found as
isolated defects with no syndromic association. Over the
past decade, a multitude of research studies have identified
both chromosomal and gene mutations as causation for
the syndromic heart malformation [5,6]. While the origin
of non-syndromic CHD that accounts for most of all
congenital cardiac abnormalities is still under the veil
waiting to be further uncovered. Relatively less informa-
tion has been reported on noninherited factors that may
have an adverse effect on the cardiovascular development,
which has made it difficult to create population-based
strategies to reduce the burden of illness from CHDs
and for couples to choose lifestyles to reduce the risk of
delivering a child with CHDs.
Recent epidemiologic studies have demonstrated an
association between maternal lifestyle factors, specifically
smoking, alcohol, illicit drugs use, caffeine use, body
mass index and psychological factors and the risk of
CHDs in offspring. A review published on 2007 provided
a summary of well-known prenatal maternal conditions ord. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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defects [7]. As part of noninherited risk factors, we
conducted a brief overview of studies on the evidence
linking common maternal lifestyle factors during preg-
nancy to the development of CHDs in offspring.
Maternal lifestyle factors and CHD
The studies that reported the association between maternal
lifestyle factors during pregnancy and the risk of offspring
with CHDs were summarized in Table 1.
Evidence of maternal smoking during pregnancy and CHD
A study by Alberman et al. [31] was one of the first to
report the association between maternal cigarette smoking
and CHDs. However, the evidence since then has been
mixed, with some studies showing positive associations
and others providing null results. To date, a total of three
meta-analyses have investigated the association between
maternal smoking during pregnancy and CHDs in off-
spring. The first meta-analysis published on1999 found no
association for all CHDs combined (OR, 1.07; 95% CI,
0.98-1.17) and mixed results for analyses of specific
groups or phenotypes [8]. The second meta-analysis by
Hackshaw et al. [9] estimated the effects of maternal
smoking across a spectrum of birth defects including
heart defects (OR, 1.09; 95% CI, 1.02-1.17). However, the
study did not evaluate the effects of maternal smoking on
CHD subtypes, and dose–response relationships (i.e.,
increasing levels of smoking) were not assessed. A latest
meta-analysis [10] of studies published between 1971 and
2011 (23 case–control studies, 5 cohort studies, and 5
cross-sectional studies) found positive association for all
CHDs combined (RR, 1.11; 95% CI, 1.02-1.21). According
to analysis, as for specific groups, women who smoked
during pregnancy were more likely to give birth to a child
with 12 of 17 CHD subtypes analyzed compared with
nonsmoker. The highest risk was for septal defects as a
group (RR, 1.44; 95% CI, 1.16-1.79). After that, a recent
study reported that only valvar pulmonary stenosis(VPS)
was highly associated with mothers who smoked 20
cigarettes or more per day (P = 0.03). When both mother
and father consumed at least 20 cigarettes per day, VPS
and coarctation of the aorta would have a significant
p-value (0.03 and 0.02 respectively) [32]. Another study
reported as opposed to smoking or high BMI alone, the
risk for CHD in the offspring of women with high BMI
(≥25 kg/m2) who also smoked was significantly increased.
The adjusted OR was 2.65 (95% CI, 1.20-5.87) for all
CHD, 2.60 (95% CI, 1.05- 6.47) for septal defects and 3.58
(95% CI, 1.46- 8.79) for outflow tract anomalies [11].
Recent analyses of small case groups based on the
National Birth Defects Prevention Study(NBDPS) data
have identified associations between maternal smoking
and atrioventricular septal defects (AVSDs) [12].The different results for analyses of specific groups of
CHDs probably reflect methodological limitations, and
other environmental factors. Further research based on
large population using standardized ascertainment of case
and classification methods is needed to determine whether
there is an association between maternal smoking and the
risk of CHDs in offspring.
Evidence of maternal alcohol consumption during
pregnancy and CHD
Ever since the first description of the fetal alcohol syn-
drome by Jones and Smith in 1973 [33], many observa-
tional studies have been published on the topic of alcohol
consumption in pregnant women and the effects on the
development of their fetus and child, including cardiac
defects. Recently, a total of seven studies investigate
the association between maternal alcohol consumption
during the pregnancy and CHDs. A population-based
case–control study of California births indicated that
compared with nonconsumers, women who consumed
alcohol less than once a week had a 1.3-fold higher risk of
having infants with a conotruncal heart defect (95% CI,
1.00- 1.90), and women who consumed alcohol once a
week or more had a 1.9-fold increase in risk (95% CI,
1.00- 3.40) [13]. In another population-based case–control
study among a cohort of California births between July
1999 and June 2003, maternal consumption of alcohol less
than one day per week was associated with a 2.1-fold
increased risk of d-transposition of the great arteries (95%
CI, 1.10- 3.20) [14]. According to a cohort study including
80,346 pregnant women enrolled into the Danish National
Birth Cohort, exposure to low-to-moderate levels of
alcohol on a weekly basis or occasional binge drinking
during pregnancy was not statistical significantly in-
creased risk of isolated ventricular septal defect(VSD)
and atrial septal defect(ASD) in offspring [15]. For
binge drinking, a case–control study in the Pregnancy
Risk Assessment Monitoring System (PRAMS) showed
significantly increased risk of CHDs among mothers
who reported binge drinking more than once compared
to mothers who did not report binge drinking in the
3 months prior to pregnancy (OR, 2.99; 95% CI, 1.19-
7.51) [16]. Two more recent cohort studies in Canada
and Australia reported a significant association between
maternal alcohol consumption during pregnancy and
overall CHDs (OR, 1.90; 95% CI, 1.70- 2.00) or ASD
(OR, 1.36; 95% CI, 1.14- 1.63) and VSD (OR, 1.77; 95% CI,
1.27- 2.46), respectively [17,18]. However, other studies
have failed to identify an association [19].
Evidence of maternal illicit drug use during pregnancy
and CHD
Illicit drug use was recorded for marijuana, hashish,
cocaine, hallucinogens, heroin, and methadone. Marijuana
Table 1 Maternal lifestyle factors and the risk of offspring with congenital heart defects
Maternal
lifestyle factors
Study design Study period Outcome Exposure OR(95% CI) Reference
Cigarette smoking Meta-ananlysis 1971-1999 CHD combined Smoking 1.07(0.98-1.17) [8]
Meta-ananlysis 1959-2010 CHD combined Smoking 1.09(1.02-1.17) [9]
Meta-ananlysis 1971-2011 CHD combined Smoking 1.11(1.02-1.21) [10]
VSD Smoking 1.44(1.16-1.79)
Case–control 1997-2008 CHD combined Smoking, BMI ≥25 kg/m2 2.65(1.20-5.87) [11]
Septal defects Smoking, BMI ≥25 kg/m2 2.60(1.05-6.47)
Outflow tract anomalies Smoking, BMI ≥25 kg/m2 3.58(1.46-8.79)
Case–control 1997-2005 AVSD Smoking 1.50(1.10- 2.40) [12]
Alcohol consumption Case–control 1987-1988 CTD Drink less than once a week 1.30(1.10-1.90) [13]
Drink once a week or more 1.90(1.00-1.34)
Case–control 1999-2003 TGA Drink less than one day per week 2.10(1.10- 3.20) [14]
Cohort 1996-2002 VSD Low-to-moderate levels of alcohol 1.10(0.54- 2.23) [15]
ASD Low-to-moderate levels of alcohol 0.66(0.27- 1.62)
Case–control 1996-2005 CHD combined Binge drinking 2.99(1.19- 7.51) [16]
Cohort 1983-2007 ASD Alcohol Diagnosis 1.36(1.14- 1.63) [17]
VSD Alcohol Diagnosis 1.77(1.27 2.46)
Cohort 2002-2010 CHD combined Alcohol use 1.90(1.70- 2.00) [18]
Case–control 1999-2005 CHD combined Drink several times a week 1.73(0.52- 5.70) [19]
Drink several times a month 1.34(0.79-2.24)
Illicit drug use Case–control 1968-1980 VSD Cannabis use 2.35(1.43- 3.86) [20]
Cannabis use for three
or more days per week
3.73(1.56- 8.96)
Case–control 1981-1989 VSD Cocaine 2.99(1.69-5.30) [21]
Case–control 1981-1989 Single ventricle Marijuana 0.90(0.10- 6.90) [22]
Caffeine Use Systematic review 1966-2004 CHD combined Coffee 1.10(0.90- 1.50) [23]
Tea 1.00(0.90-1.20)





Case–control 1991-1993 CHD in Down syndrome ≥4 cups of coffee vs. <4 cups 1.50(0.70-3.30) [25]
BMI Meta-ananlysis 1996-2008 CHD combined Obesity 1.30(1.12-1.51) [26]
Septal anomalies Obesity 1.20(1.09-1.31)
TOF Obesity 1.10(0.76-1.61)
TGA Obesity 1.41(0.97-2.06)
Meta-ananlysis 1969-2012 CHD combined Overweight 1.08(1.02-1.15) [27]
Moderate obesity 1.15(1.11-1.20)
Severe obesity 1.39(1.31-1.47)
TOF Severe obesity 1.94(1.49-2.51)
AVS Underweight 1.47(1.01-2.15)
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Table 1 Maternal lifestyle factors and the risk of offspring with congenital heart defects (Continued)




Psychological factors Case–control 1978-2008 CHD combined Bereavement 1.11(1.00-1.22) [29]
Case–control 2004-2005 CHD combined Mental stress 3.93(1.94-7.94) [30]
Case–control 1996-2005 CHD combined High stress level vs. low stress level 0.74(0.45-1.22) [25]
Abbreviation: CHD, congenital heart defect; VSD, Ventricular Septal Defect; ASD, Atrial Septal Defect; TOF, Tetralogy of Fallot; TGA, Transposition of the Great
Arteries; AVSD, Atrioventricular Septal Defect; CTD,Conotruncal defects; PVS, Pulmonary valve stenosis; COA, Coarctation of the aorta; AVS, Aortic valve stenosis;
PAS, pulmonary artery stenosis.
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ure. A case–control study in Atlanta reported maternal
cannabis use, according to self- and proxy-report, was
associated with a two-fold increased risk of VSD. Self-
reported cannabis use for fewer than three days per week
resulted in a similar OR, while use three or more days
per week resulted in an almost four-fold increased risk
(OR, 3.73; 95% CI, 1.56- 8.96) [20]. A case–control study
using data from the Baltimore-Washington Infant Study
(BWIS) examined the association between maternal cocaine
use and isolated membranous ventricular septal defects
(VSD). An OR of 2.99 for maternal cocaine use dropped to
2.15 when taking into account paternal cocaine use
(a change of 28%) and to 2.52 when paternal marijuana
use was considered (a change of 16%). Although maternal
cocaine use was an effect modifier for paternal cocaine
use, it was not statistically significant as an independent
risk factor [21]. Another case–control study of single ven-
tricle using data from the BWIS reported no association
between maternal marijuana and single ventricle in infants
(OR, 0.90; 95% CI, 0.10-6.90) [22]. Further studies are
warranted to elucidate the possible association of illicit
drug use with CHDs in offspring.
Evidence of maternal caffeine use during pregnancy
and CHD
Caffeine is a natural component of coffee, tea, cocoa, and
cola products. It is teratogenic in animal studies when
administered at high concentrations [34]. In humans,
caffeine and its metabolites easily cross the placenta
and reach the fetus [24]. Most studies on the human
teratogenicity of caffeine have not shown an important
effect. In a systematic review published on 2006 [23] inves-
tigating the association between maternal exposure to
caffeine and risk of congenital anomalies, slight elevations
were observed for associations between coffee intake and
cardiovascular malformations (OR, 1.10; 95%CI, 0.90-
1.50), but not for the association between tea and
cardiovascular malformations (OR, 1.00; 95%CI, 0.90-
1.20). Fixler and colleagues observed an OR of 0.75 (95%
CI, 0.39-1.44) for the occurrence of cardiac defects withcoffee consumed daily and an OR of 0.89 (95% CI, 0 .42-
1.88) for consumption of caffeine in general [24]. In a
case–control study which evaluated risk factors present
during early pregnancy in a multiracial population of 687
infants with Down syndrome, the proportion of mothers
who drank four or more cups of coffee daily (4.2%) was
too small to analyze high caffeine intake from either tea or
soft drinks [25].
Evidence of maternal body mass index during pregnancy
and CHD
Nowadays, obesity rates have an increasing tendency,
since the incidence of obesity in both developed and de-
veloping countries is still rising over the years. Epidemi-
ologic data from the National Health and Nutrition
Examination Survey described that, from 2007–2008,
28-32% of childbearing-aged women were obese and that
7.2-8.4% of them were morbidly obese (BMI ≥ 40 kg/m2)
[35]. From a public health perspective, recent studies
have highlighted the increased risks that are associated
with obesity in pregnancy and have appealed for optimal
treatment of the pre gravid obese women. Numerous
studies have shown that obese women appear to be at a
higher risk of pregnancy complications, such as pre-
eclampsia, gestational diabetes mellitus, preterm deliv-
ery, and cesarean delivery [36-39], as well as adverse
fetal and neonatal outcomes, such as congenital heart
defect. A meta-analysis of 18 studies published between
1966 and 2008 found an association of maternal obesity
with an increased risk of cardiovascular anomalies (OR,
1.30; 95% CI, 1.12-1.51) and septal anomalies (OR, 1.20;
95% CI, 1.09-1.31) [26]. A recent meta-analysis of 14
epidemiological studies [27] demonstrated an association
between overweight, moderate obesity, and severe obes-
ity and all CHD combined (OR, 1.08, 95% CI, 1.02-1.15;
OR, 1.15, 95% CI, 1.11-1.20; and OR, 1.39, 95% CI, 1.31-
1.47, respectively) as well as some individual defects
such as pulmonary valve stenosis, hypoplastic left heart
syndrome, and outflow tract defects, with the highest
risk of tetralogy of Fallot for obese mothers for (OR,
1.94; 95% CI, 1.49-2.51). Being underweight did not
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did increase the risk of aortic valve stenosis (OR, 1.47;
95% CI, 1.01-2.15). In a more recent case–control study
that evaluated the risk of congenital anomalies with
different doses of maternal pre-pregnancy obesity in
Florida, five CHD phenotypes showed evidence of a
dose–response pattern with increasing severity of mater-
nal obesity corresponding to increased odds of each
defect [28]. In case–control studies, obesity is a complex
condition that should to be studied carefully to minimize
underreporting of body weight. We also should take into
account the possibility of confounding by other factors
associated with nutrition, such as the use of multivita-
min supplements or intake of micronutrients.
Evidence of maternal psychological factors and CHD
Maternal stress is measured by maternal reports of divorce,
separation, job loss, or death of a close relative or friend. A
large registry-based study reported maternal emotional
stress may be a risk factor for CHDs in infants, using
bereavement around conception as an indicator of mater-
nal exposure to stress (OR =1.11, 95% CI 1.00–1.22). The
association was most for infants of mothers who had lost
a partner or child (OR =1.32, 1.04–1.67) [29]. Maternal
mental stress during early pregnancy was significant asso-
ciated with aggregate cardiac defects in a hospital-based
case–control study of 164 patients with CHDs (OR, 3.93;
95% CI, 1.94–7.94) [30]. No increased risk of major car-
diac malformations among offspring was seen of women
who had high stress level compared with low stress level
in a case–control study of 237 cases [16].
Discussion and conclusion
The reviewed studies indicate that maternal lifestyle factors
during pregnancy may contribute to congenital heart
defects in the offspring. However, because of differences
in methods, these studies are only suggestive. The major-
ity of studies found an association between exposure to
tobacco smoking during pregnancy and infant’s risk of
CHDs, but not all subtypes of CHDs. The results for
alcohol exposure were also inconsistent, and some papers
included in this review only showed a statistically signifi-
cant association with specific groups or phenotypes. Only
half of the papers showed a statistically significant associ-
ation between maternal illicit drug use during pregnancy
and CHD. Most studies showed that increasing maternal
body mass index was associated with an increased risk of
CHDs; severe obesity was an even greater risk factor
for the development of CHDs. However, the results for
studies about maternal caffeine use and psychological
factors were mixed.
In interpreting findings on possible associations between
maternal lifestyle factors and CHDs, we must remember
that such associations from observational studies may bedue to the exposures or factors of interest, but they
may also be a result of chance, bias, or confounding. An
observational study can yield an association as a result of
sampling variation of the controls or multiple comparisons
in an exploratory study. Since the assessment of exposure
to many factors is often based on parental recall after the
birth of the child, recall bias should be concerned [7].
The mechanisms by which maternal lifestyle factors
may result in CHDs still remain unknown. Findings have
shown that maternal smoking has adverse effects on the
developing fetus, including hypoxia caused by carbon
monoxide, nicotine, and reduction in the supply of essential
nutrients to the embryonic tissues [40,41]. Additionally,
polycyclic aromatic hydrocarbons, common components
of cigarette smoke, are suspected teratogens in laboratory
animals and humans [42,43]. The mechanisms by which
alcohol consumption may result in CHDs remain to get
confirmed, even though its etiology has been the focus
of much study, especially the cellular and molecular
mechanisms [44-46]. Additionally, findings have shown
that alcohol consumption during pregnancy may affect
the Wnt/β-catenin signaling which allows normal gene
activation and cardiogenesis [47]. Cell death is a hypothe-
sized mechanism for muscular VSD formation and alcohol
exposure has been shown to result in abnormal cell
development and cell death [48]. Cocaine or marijuana,
a vasoconstrictor, has been investigated as a potential
teratogen because exposure may result in vascular disrup-
tions and hypoperfusion. Some studies among humans
have reported intake of caffeine or coffee could induce
increased levels of homocysteine and decreases in insulin
sensitivity [49]. Vascular disruption, increased homocyst-
eine levels, and oxidative stress associated with hypergly-
cemia are potential mechanisms for various congenital
malformations [50-52]. For the same reason, women who
are obese might have diabetes mellitus, which appears
to be an important pathogenetic factor that is associated
with a wide spectrum of CHDs [53]. Maternal stress could
affect fetal development by several plausible mechanisms,
such as catecholamine production and corticosteroid pro-
duction, which may be associated with the development of
birth defects. Another potential mechanism is that stress
may lead to harmful coping behaviors (e.g., increased
substance use or cigarette smoking or decreased dietary
quality) and therefore affect development indirectly.
In conclusion, this review summarizes the current state
of knowledge of maternal lifestyle factors that may increase
the likelihood of congenital heart defects in offspring. To
date, no public policies or interventions are specifically
directed at reducing the public health impact of congenital
heart defects [7]. Our findings could cause public health
policy makers to pay more attention to at-risk populations
and could be used in the development of population-based
prevention strategies to reduce the incidence and burden of
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have an excessive BMI. However, more prospective studies
are needed to further investigate the association between
maternal lifestyle factors and CHDs, especially with regard
to the different subtypes of CHDs.
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